Show simple item record

dc.contributor.advisorFredheim, Elizabeth Aarag
dc.contributor.authorHasund, Camilla Remøy
dc.date.accessioned2019-06-06T07:28:14Z
dc.date.available2019-06-06T07:28:14Z
dc.date.issued2017-05-16
dc.description.abstractThe escalating emergence of AMR is a growing public health concern, and a result of the use and misuse of antibiotics since its introduction. To prevent the development of resistance and preserve the efficacy of antimicrobial agents, new treatment strategies is of utmost importance. One possible approach may be to take advantage of collateral sensitivity, a phenomenon where bacteria acquiring resistance to one antimicrobial drug simultaneously became more sensitive to others. Our aim in this project is to investigate the generality of collateral sensitivity in clinical urinary tract isolates of E. coli. In addition, we wanted to investigate effects of the mutations on biofilm forming ability of the resistant mutants.en_US
dc.identifier.urihttps://hdl.handle.net/10037/15466
dc.language.isoengen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2017 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)en_US
dc.subject.courseIDFAR-3911
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800en_US
dc.titleCollateral sensitivity in clinical Escherichia coli isolates resistant to ciprofloxacin and/or mecillinamen_US
dc.typeMaster thesisen_US
dc.typeMastergradsoppgaveen_US


File(s) in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)